Metabolic dysregulation of tricarboxylic acid cycle and oxidative phosphorylation in glioblastoma

• Published in: Reviews in the neurosciences
• Main Authors: Trejo-Solís, Cristina, Serrano-García, Norma, Castillo-Rodríguez, Rosa Angelica, Robledo-Cadena, Diana Xochiquetzal, Jimenez-Farfan, Dolores, Marín-Hernández, Álvaro, Silva-Adaya, Daniela, Rodríguez-Pérez, Citlali Ekaterina, Gallardo-Pérez, Juan Carlos
• Format: Journal Article
• Language: English
• Published: 07.06.2024
• ISSN: 0334-1763; 2191-0200
• DOI: 10.1515/revneuro-2024-0054

Abstract Glioblastoma multiforme (GBM) exhibits genetic alterations that induce the deregulation of oncogenic pathways, thus promoting metabolic adaptation. The modulation of metabolic enzyme activities is necessary to generate nucleotides, amino acids, and fatty acids, which provide energy and metabolic intermediates essential for fulfilling the biosynthetic needs of glioma cells. Moreover, the TCA cycle produces intermediates that play important roles in the metabolism of glucose, fatty acids, or non-essential amino acids, and act as signaling molecules associated with the activation of oncogenic pathways, transcriptional changes, and epigenetic modifications. In this review, we aim to explore how dysregulated metabolic enzymes from the TCA cycle and oxidative phosphorylation, along with their metabolites, modulate both catabolic and anabolic metabolic pathways, as well as pro-oncogenic signaling pathways, transcriptional changes, and epigenetic modifications in GBM cells, contributing to the formation, survival, growth, and invasion of glioma cells. Additionally, we discuss promising therapeutic strategies targeting key players in metabolic regulation. Therefore, understanding metabolic reprogramming is necessary to fully comprehend the biology of malignant gliomas and significantly improve patient survival.